Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's disease.
Figueiras-Méndez
R
R
Marín-Zarza
F
F
Antonio Molina
J
J
Jiménez-Jiménez
F J
FJ
Ortí-Pareja
M
M
Magariños
C
C
López-Pino
M A
MA
Martínez
V
V
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004599:Electric Stimulation Therapy; D004567:Electrodes, Implanted; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D009069:Movement Disorders / Q000209:etiology* / Q000517:prevention & control*; D010300:Parkinson Disease / Q000188:drug therapy*; D013787:Thalamic Nuclei / Q000601:surgery; D013788:Thalamus / Q000601:surgery
D000978:Antiparkinson Agents; D007980:Levodopa